— Know what they know.
Not Investment Advice
Also trades as: GXI.DE (XETRA) · $vol 5M · GXI.SW (SIX) · $vol 0M

GRRMF OTC

Gerresheimer AG
1W: +0.0% 1M: -9.8% 3M: -4.8% YTD: -43.5% 1Y: -43.5% 3Y: -60.8% 5Y: -61.1%
$29.05
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Strong Sell · Power 38 · $1.0B mcap · 32M float · 0.0005% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$2.0B +2.3% ▲
5Y CAGR: +7.9%
Gross Profit
$608M +1.7% ▲
5Y CAGR: +17.0%
Operating Income
$197M -7.5% ▼
5Y CAGR: +9.8%
Net Income
$110M -5.5% ▼
5Y CAGR: +6.3%
EPS (Diluted)
$3.18 -8.6% ▼
5Y CAGR: +4.4%
EBITDA
$406M +0.5% ▲
5Y CAGR: +8.2%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$1.4B$1.5B$1.8B$2.0B$2.0B
YoY Growth+1.9%+5.6%+21.3%+9.5%+2.3%
Cost of Revenue$981M$1.1B$1.3B$1.4B$1.4B
Gross Profit$438M$442M$547M$597M$608M
Gross Margin30.8%29.5%30.1%30.0%29.9%
R&D Expenses$8M$12M$22M$19M$22M
SG&A Expenses$275M$285M$305M$326M$342M
Operating Expenses$258M$263M$377M$384M$410M
Operating Income$156M$147M$169M$213M$197M
Operating Margin11.0%9.8%9.3%10.7%9.7%
Interest Expense$21M$21M$29M$50M$61M
Income Before Tax$135M$128M$141M$167M$147M
Tax Expense$45M$41M$39M$47M$34M
Net Income$89M$84M$96M$116M$110M
Net Margin6.2%5.6%5.3%5.8%5.4%
EPS (Diluted)$2.82$2.67$3.06$3.48$3.18
EBITDA$301M$294M$340M$404M$406M
Shares Outstanding31M31M31M33M35M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms